IDG Capital

Activity from announced rounds

Activity in this selectionsf-group-69d8b78d
Rounds participated in
2
Confirmed lead rounds
2
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$290M
1 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

AI1
Biotech1

By country

China2

Rounds

2 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Apex Intelligence

Apex Intelligence is developing self-evolving foundation models to help researchers generate and test scientific hypotheses.

Lead